FindTrial
Sign In

Analysis of the effect of positive inotropic drugs on lactate after CPB based on the MIMICIII database

Analysis of the effect of positive inotropic drugs on lactate after CPB based on the MIMICIII database

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200057347
Enrollment
Unknown
Registered
2022-03-09
Start date
2022-03-07
Completion date
Unknown
Last updated
2023-10-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiopathy

Interventions

None listed

Sponsors

Central China Fuwai Hospital of Zhengzhou University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients undergoing the following operations: 1. Coronary artery bypass grafting under extracorporeal circulation; 2. Aortic valve replacement or repair; 3. Mitral valve replacement or repair; 4. Tricuspid valve replacement or repair; 5. Cardiac tumor resection; 6. Thoracoabdominal aortic replacement; 7. Palliative or corrective procedures for congenital heart diseases, such as septal defect repair, atrial septal defect repair, endocardial cushion defect repair, and correction of tetralogy of Fallot, etc.; 8. Single/biventricular assist device implantation.

Exclusion criteria

Exclusion criteria: 1. Patients treated without cardiopulmonary bypass during non-cardiac surgery.

Design outcomes

Primary

MeasureTime frame
ICU stay Time;API III score;SOFT score;Lactic acid peak;Lactic acid value;Total amount and maximum rate of positive inotropic drugs;—

Countries

China

Contacts

Public ContactLi Yanan

Central China Fuwai Hospital of Zhengzhou University

1033070179@qq.com+86 19137621271

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026